Literature DB >> 23529546

Protection against peroxynitrite-induced DNA damage by mesalamine: implications for anti-inflammation and anti-cancer activity.

Paul M Graham1, Jason Z Li, Xueging Dou, Hong Zhu, Hara P Misra, Zhenquan Jia, Yunbo Li.   

Abstract

Mesalamine (5-aminosalicylic acid, 5-ASA) is known to be the first-line medication for treatment of patients with ulcerative colitis. Studies have demonstrated that ulcerative colitis patients treated with 5-ASA have an overall decrease in the risk of developing colorectal carcinoma. However, the mechanisms underlying 5-ASA-mediated anti-inflammatory and anti-cancer effects are yet to be elucidated. Because peroxynitrite has been critically involved in inflammatory stress and carcinogenesis, this study was undertaken to investigate the effects of 5-ASA in peroxynitrite-induced DNA strand breaks, an important event leading to peroxynitrite-elicited cytotoxicity. Incubation of φX-174 plasmid DNA with the peroxynitrite generator 3-morpholinosydnonimine (SIN-1) led to the formation of both single- and double-stranded DNA breaks in a concentration-dependent manner. The presence of 5-ASA at 0.1 and 1.0 mM was found to significantly inhibit SIN-1-induced DNA strand breaks in a concentration-dependent manner. The consumption of oxygen induced by SIN-1 was found to not be affected by 5-ASA at 0.1-50 mM, indicating that 5-ASA at these concentrations is not involved in the auto-oxidation of SIN-1 to form peroxynitrite. It is observed that 5-ASA at 0.1-1 mM showed considerable inhibition of peroxynitrite-mediated luminol chemiluminescence in a dose-dependent fashion, suggesting that 5-ASA is able to directly scavenge the peroxynitrite. Electron paramagnetic resonance (EPR) spectroscopy in combination with spin-trapping experiments, using 5,5-dimethylpyrroline-N-oxide (DMPO) as spin trap resulting in the formation of DMPO-hydroxyl radical adduct from peroxynitrite, and 5-ASA only at higher concentration (1 mM) inhibited the hydroxyl radical adduct while shifting EPR spectra, indicating that 5-ASA at higher concentrations may generate a more stable free radical species rather than acting purely as a hydroxyl radical scavenger. Taken together, these studies demonstrate for the first time that 5-ASA can potently inhibit peroxynitrite-mediated DNA strand breakage, scavenge peroxynitrite, and affect peroxynitrite-mediated radical formation, which may be responsible, at least partially, for its anti-inflammatory and anti-cancer effects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529546     DOI: 10.1007/s11010-013-1620-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Metallothionein inhibits peroxynitrite-induced DNA and lipoprotein damage.

Authors:  L Cai; J B Klein; Y J Kang
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 2.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  [Guidelines for the management of ulcerative colitis].

Authors:  Chang Hwan Choi; Young-Ho Kim; You Sun Kim; Byong Duk Ye; Kang Moon Lee; Bo In Lee; Sung-Ae Jung; Won Ho Kim; Heeyoung Lee
Journal:  Korean J Gastroenterol       Date:  2012-02

4.  Enhanced chemiluminescent reactions catalyzed by horseradish peroxidase.

Authors:  G H Thorpe; L J Kricka
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactions.

Authors:  R A Radi; H Rubbo; E Prodanov
Journal:  Biochim Biophys Acta       Date:  1989-01-19

Review 6.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

Review 7.  Ulcerative colitis and cancer.

Authors:  Mahmoud N Kulaylat; Merril T Dayton
Journal:  J Surg Oncol       Date:  2010-06-15       Impact factor: 3.454

Review 8.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics.

Authors:  Csaba Szabó; Harry Ischiropoulos; Rafael Radi
Journal:  Nat Rev Drug Discov       Date:  2007-08       Impact factor: 84.694

9.  Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage.

Authors:  Sun Yee Kim; Jin Hyup Lee; Eun Sun Yang; In Sup Kil; Jeen-Woo Park
Journal:  Biochem Biophys Res Commun       Date:  2003-02-14       Impact factor: 3.575

10.  Bicarbonate plays a critical role in the generation of cytotoxicity during SIN-1 decomposition in culture medium.

Authors:  Kyo Shirai; Tatsumi Okada; Kanako Konishi; Hiroshi Murata; Soichiro Akashi; Fumio Sugawara; Nobuo Watanabe; Takao Arai
Journal:  Oxid Med Cell Longev       Date:  2012-07-09       Impact factor: 6.543

View more
  4 in total

1.  Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.

Authors:  Sonam Dilwali; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Konstantina M Stankovic
Journal:  Transl Res       Date:  2015-01-07       Impact factor: 7.012

Review 2.  Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.

Authors:  Aleksandra Piechota-Polanczyk; Jakub Fichna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-05-06       Impact factor: 3.000

3.  Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.

Authors:  Jean-Paul Motta; Thibault Allain; Luke E Green-Harrison; Ryan A Groves; Troy Feener; Hena Ramay; Paul L Beck; Ian A Lewis; John L Wallace; Andre G Buret
Journal:  Inflamm Bowel Dis       Date:  2018-06-08       Impact factor: 5.325

4.  The Radical Scavenger NZ-419 Suppresses Intestinal Polyp Development in Apc-Mutant Mice.

Authors:  Yurie Kurokawa; Gen Fujii; Susumu Tomono; Shingo Miyamoto; Takahiro Hamoya; Maiko Takahashi; Takumi Narita; Masami Komiya; Masaki Kobayashi; Yoshikazu Higami; Michihiro Mutoh
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.